Y-Intercept (HK)’s Celularity CELU Stock Holding History

Y-Intercept (HK)’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,815	Closed	-$78.9K	–	1111
2023 Q2	$78.9K	Buy	14,815 +10,661	+257%	+$68.3K	0.01%	1140
2023 Q1	$25.7K	Buy	+4,154	New	+$33.4K	﹤0.01%	1125

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s CELU Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Celularity (CELU) in Q3 2023, closing a stake of 14,815 shares — an estimated $78.9K sold.

Y-Intercept (HK) first reported a position in CELU in Q1 2023 and held it in 2 quarters. The position peaked at $78.9K in Q2 2023. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

Y-Intercept (HK) reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 14,815 Celularity shares in Q3 2023, an estimated $78.9K.
Y-Intercept (HK) first reported a position in Celularity in Q1 2023 and held it in 2 quarters.
Y-Intercept (HK)'s Celularity position peaked at $78.9K in Q2 2023.
45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.